Everyone has been waiting to hear about Aljamain Sterling’s next title defense. Sterling has defensed his bantamweight belt twice. Henry Cejudo has been waiting for quite a while to formalize his return to the UFC due to Sterling’s difficulty recovering from an injury.
Sterling just revealed that he’ll be defending his title against Cejudo at UFC 288 in May.
“I can’t wait for this matchup, because I think that it’s two guys that won’t back down, and I think the wrestling might cancel each other out – we will see if I’m able to rag-doll him,” he said on his Youtube channel.
Sterling went on to offer sparse excuses for how he started his run as a bantamweight champion:
“At the end of the day I will forever be known as a UFC champion called the DQ and acting whatever you want. Okay, cool. I did. And guess what I came back redeemed myself and guess where I’m at now. So it’s not my fault TJ tore his arm…”
Aljamain Sterling reportedly suffered a bicep tear several camps ago and has wanted to sort it in fall out from facing TJ Dillashaw. He reportedly went to a stem cell place in Columbia that was recommended by Joe Rogan. In addition to Sterling, Kamaru Usman also pursued treatment there.
“I knew [stem cell treatments at] bioXccelerators are going to be very good. I’m very optimistic about that and I think it’s going to get me back to 100 percent so I can compete against a tough competitor like Triple Zero and remind him that he should have stayed retired.”
Rogan told Jamahal Hill that Kamaru Usman was also in Columbia during the podcast episode:
” A lot of guys are going to do that bio accelerator place down in Columbia and getting stem cells. It really helped you recover, especially for injuries. It cuts the time down. I was just talking to somebody.”
“They have a lock down on what you’re allowed to do here in the United States, even though it’s highly effective and even though you’re dealing with injured people that really should have every option available to them. Especially when some of these options are proven to be effective.”
Embryonic stem cell research has been controversial due to ethical concerns surrounding the use of human embryos, which has led to funding restrictions and limited research in this area. However, there is ongoing research exploring the potential of induced pluripotent stem cells (iPSCs), which are adult cells that have been reprogrammed to behave like embryonic stem cells. iPSCs offer a promising alternative to embryonic stem cells for research and therapeutic applications.